Skip to main content

Table 2 Baseline Characteristics

From: Relationship between CMR-derived parameters of ischemia/reperfusion injury and the timing of CMR after reperfused ST-segment elevation myocardial infarction

Characteristics Overall
(n = 163)
Tertile-1
(n = 54)
Tertile-2
(n = 55)
Tertile-3
(n = 54)
P-value
Age (years) 60 ± 13 60 ± 14 57 ± 14 63 ± 11 0.054
Male Gender  n, (%) 120 (74) 40 (74) 39 (71) 41 (76) 0.835
FH for CAD n, (%) 19 (12) 9 (17) 6 (11) 4 (7) 0.318
Diabetes n, (%) 24 (15) 7 (13) 5 (9) 12 (22) 0.139
Hypertension n (%) 90 (55) 27 (50) 28 (51) 35 (65) 0.219
Hypercholesterolemia n, (%) 92 (53) 30 (56) 33 (60) 29 (54) 0.658
Active Smoking n, (%) 66 (40) 20 (37) 26 (47) 20 (37) 0.453
Prodromal Angina n. (%) 55 (34) 19 (35) 20 (36) 16 (30) 0.731
Time-to-PPCI (min) 195 (128–270) 209 (129–270) 173 (125–208) 197 (149–303) 0.111
Systolic blood pressure (mmHg) 119 ± 21 124 ± 22 120 ± 21 114 ± 20 0.061
Diastolic blood pressure (mmHg) 70 ± 14 71 ± 15 72 ± 14 68 ± 13 0.368
Heart Rate (bpm) 75 ± 16 74 ± 14 73 ± 15 78 ± 19 0.165
RPP before PPCI (mmHg∙bpm) 9032 ± 2713 9296 ± 2780 8779 ± 2547 9027 ± 2831 0.613
Infarct related artery n, (%)      0.537
 LAD 74 (45) 28 (52) 23 (42) 23 (43)
 RCA 62 (38) 17 (31) 25 (46) 20 (37)
 LCX 27 (17) 9 (17) 7 (13) 11 (20)
Anterior Infarction n, (%) 74 (45) 28 (52) 23 (41) 23 (43) 0.506
Non-IRA critical stenosis n, (%)      0.865
 0 79 (49) 28 (52) 28 (51) 23 (43)  
 1 51 (31) 15 (25) 17 (31) 19 (35)  
 2 33 (20) 11 (20) 10 (18) 12 (22)  
TIMI flow-grade pre-PPCI n, (%)      0.237
 0,1 121 (74) 40(74) 37 (67) 44 (82)  
 2,3 42 (26) 14 (26) 18 (33) 10 (19)  
TIMI flow-grade post-PPCI n, (%)      0.444
 0,1 2 (1) 0(0) 1 (2) 1 (2)  
 2,3 161 (99) 54 (100) 54 (98) 53 (98)  
Rentrop flow-grade n, (%)      0.152
 0,1 152 (93) 53 (98) 50 (91) 49 (91)  
 2,3 11 (7) 1 (2) 5 (9) 5 (9)  
Medication at discharge  
ACEi or ARBs n, (%) 160 (98) 53 (98) 53 (96) 54 (100) 0.369
Beta-blockers n, (%) 126 (77) 39 (72) 44 (80) 43 (80) 0.552
Statins n, (%) 154 (95) 51 (94) 54 (98) 53 (98) 0.458
Diuretics n, (%) 13 (8) 2 (4) 4 (7) 7 (13) 0.197
  1. ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CAD coronary artery disease, FH familial history, IRA infarct-related artery, LAD left anterior descending artery, LCX:left circumflex, PPCI primary percutaneous coronary intervention, RCA right coronary artery, RPP rate-pressure product, TIMI Thrombolysis In Myocardial Infarction